Abstract:Background and objective: Peak width of skeletonized mean diffusivity (PSMD), a fully automated diffusion tensor imaging (DTI) biomarker of white matter (WM) microstructure damage, has been shown to be associated with cognition in various WM pathologies. However, its application in schizophrenic disease remains unexplored. This study aims to investigate PSMD along with other DTI markers in first-episode schizophrenia patients compared to healthy controls (HCs), and explore the correlations between these metrics and clinical characteristics. Methods: A total of 56 first-episode drug-naive schizophrenia patients and 64 HCs were recruited for this study. Participants underwent structural imaging and DTI, followed by comprehensive clinical assessments, including the Positive and Negative Syndrome Scale (PANSS) for patients and cognitive function tests for all participants. We calculated PSMD, peak width of skeletonized fractional anisotropy (PSFA), axial diffusivity (PSAD), radial diffusivity (PSRD) values, skeletonized average mean diffusivity (MD), average fractional anisotropy (FA), average axial diffusivity (AD), and average radial diffusivity (RD) values as well as structural network global topological parameters, and examined between-group differences in these WM metrics. Furthermore, we investigated associations between abnormal metrics and clinical characteristics. Results: Compared to HCs, patients exhibited significantly increased PSMD values (t = 2.467, p = 0.015), decreased global efficiency (Z = -2.188, p = 0.029), and increased normalized characteristic path length (lambda) (t = 2.270, p = 0.025). No significant differences were observed between the groups in the remaining metrics, including PSFA, PSAD, PSRD, average MD, FA, AD, RD, local efficiency, normalized cluster coefficient, small-worldness, assortativity, modularity, or hierarchy (p > 0.05). After adjusting for relevant variables, both PSMD and lambda values exhibited a significant negative correlation with reasoning and problem-solving scores (PSMD: r = -0.409, p = 0.038; lambda: r = -0.520, p = 0.006). No statistically significant correlations were observed between each PANSS score and the aforementioned metrics in the patient group (p > 0.05). Multivariate linear regression analysis revealed that increased PSMD (β = -0.426, t = -2.260, p = 0.034) and increased lambda (β = -0.490, t = -2.994, p = 0.007) were independently associated with decreased reasoning and problem-solving scores respectively ( R a d j 2 = 0.295, F = 2.951, p = 0.029). But these significant correlations did not withstand FDR correction (p_FDR > 0.05). Conclusion: PSMD can be considered as a valuable neuroimaging biomarker that complements conventional diffusion measurements for investigating abnormalities in WM microstructural integrity and cognitive functions in schizophrenia.

Comparing Free Water Imaging and Magnetization Transfer Measurements in Schizophrenia.

Diffusion Tensor Mr Imaging Evaluation Of Callosal Abnormalities In Schizophrenia: A Meta-Analysis

Free-water Imaging in Subcortical Gray Matter in Schizophrenia Patients with Persistent Auditory Verbal Hallucinations.

White Matter Microstructural Abnormalities in Patients with Late-Onset Schizophrenia Identified by a Voxel-Based Diffusion Tensor Imaging

Tract-based Analysis of Magnetization Transfer Ratio and Diffusion Tensor Imaging of the Frontal and Frontotemporal Connections in Schizophrenia.

Characterizing Extracellular White Matter Pathologies Using Free Water Imaging Across the Schizophrenia Illness Course: A Multi-Site Harmonized Diffusion MRI Study

Characterization of Extracellular Free Water Pathologies in Schizophrenia Using Multi-Site Diffusion MRI Harmonization

Altered White Matter Connectivity in Never-Medicated Patients with Schizophrenia

Disentangling the pathologies linking white matter hyperintensity and geriatric depressive symptoms in subjects with different degrees of vascular impairment

Combined White Matter Imaging Suggests Myelination Defects in Visual Processing Regions in Schizophrenia

Relationships between brain water content and diffusion tensor imaging parameters (apparent diffusion coefficient and fractional anisotropy) in multiple sclerosis

Free-water diffusion tensor imaging improves the accuracy and sensitivity of white matter analysis in Alzheimer’s disease

Reduced White Matter Integrity and Cognitive Deficit in Never-Medicated Chronic Schizophrenia: A Diffusion Tensor Study Using TBSS

A Combined Dti and Structural Mri Study in Medicated-Naive Chronic Schizophrenia

Neurite Density and Free Water in the Gray and White Matter of Early Psychosis Patients

Structural Covariance of Depth-Dependent Intracortical Myelination in the Human Brain and Its Application to Drug-Naive Schizophrenia: a T1w/T2w MRI Study

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group

White matter microstructure in first-episode schizophrenia:diffusion tensor imaging study using tract-based spatial statistics analysis

Free-Water Diffusion Magnetic Resonance Imaging Differentiates Suicidal Ideation from Suicide Attempt in Treatment-Resistant Depression.

Peak width of skeletonized mean diffusivity as a neuroimaging biomarker in first-episode schizophrenia

Reduced White Matter Integrity Associated with Cognitive Deficits in Patients with Drug-Naive First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging.